QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant
Clinical trial NCT02610296 · COMPLETED
Trial details
- NCT number
- NCT02610296
- Sponsor
- Quark Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-06-28
- Enrollment
- 594
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.